Showing results (121-130 of 294) with videos related to
Sort By:
Pageof 30
Oncotarget|July 18, 2013
Anti-c-Met antibodies recognising a temperature sensitive epitope, inhibit cell growthJulin S Wong, Emma Warbrick, Borek Vojtesk, et al.Nature Reviews. Drug Discovery|March 1, 2014
Drugging the p53 pathway: understanding the route to clinical efficacyKian Hoe Khoo, Khoo Kian Hoe, Chandra S Verma, et al.Cell Cycle (Georgetown, Tex.)|September 6, 2007
Nutlin-3 inhibits the NFkappaB pathway in a p53-dependent manner: implications in lung cancer therapyAnwesha Dey, E T Wong, P Bist, et al.Cell Cycle (Georgetown, Tex.)|May 15, 2009
Crystallization of eIF4E complexed with eIF4GI peptide and glycerol reveals distinct structural differences around the cap-binding siteChristopher J Brown, Chandra S Verma, Malcolm D Walkinshaw, et al.Nature Cell Biology|March 17, 2015
Hypoxia-inducible TAp73 supports tumorigenesis by regulating the angiogenic transcriptomeIqbal Dulloo, Beng Hooi Phang, Rashidah Othman, et al.BMC Genomics|February 18, 2010
Differences in the transactivation domains of p53 family members: a computational studyJagadeesh N Mavinahalli, Arumugam Madhumalar, Roger W Beuerman, et al.Cell Cycle (Georgetown, Tex.)|October 25, 2007
Modulation of the p53-MDM2 interaction by phosphorylation of Thr18: a computational studyHui Jun Lee, Deepa Srinivasan, David Coomber, et al.Cell Cycle (Georgetown, Tex.)|November 26, 2013
On the origin of the stereoselective affinity of Nutlin-3 geometrical isomers for the MDM2 proteinKarim M ElSawy, Chandra S Verma, David P Lane, et al.Proteins|November 6, 2014
mAb806 binding to epidermal growth factor receptor: a computational studyYao Zong Ng, Srinivasaraghavan Kannan, David P Lane, et al.Bioscience Reports|November 16, 2013
A comparison and optimization of methods and factors affecting the transformation of Escherichia coliWeng-Tat Chan, Chandra S Verma, David P Lane, et al.Pageof 30